Clinical Trial Update: PEPCAD III Substudy: Stem Cell Mobilization [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 substudy of PEPCAD III evaluating stem cell mobilization in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: University Hospital, Saarland | Conditions: Coronary Artery Disease | Phase 1, Phase 2 | Status: COMPLETED